Catalent
CTLT
#1792
Rank
โ‚น1.094 T
Marketcap
โ‚น6,027
Share price
0.00%
Change (1 day)
21.89%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2024 (TTM): -โ‚น527.16

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น601.03. In 2023 the company made an earnings per share (EPS) of -โ‚น645.66 a decrease over its 2022 EPS that were of โ‚น215.54.

EPS history for Catalent from 2014 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-โ‚น527.16-18.35%
2023-โ‚น645.66-399.56%
2022โ‚น215.54-30.58%
2021โ‚น310.4979.67%
2020โ‚น172.81114.12%
2019โ‚น80.71-15%
2018โ‚น94.9575.44%
2017โ‚น54.12-22.97%
2016โ‚น70.26-59.56%
2015โ‚น173.76282.05%
2014โ‚น45.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-โ‚น182.30-69.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
โ‚น1,448-340.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-โ‚น71.21-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-โ‚น140.53-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA